BK Viremia

Clinical trial pipeline · Data from ClinicalTrials.gov

See which BK Viremia trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 3

NCT05325008

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

BEAT-BK will see the effect of immunosuppression reduction/modification with and without IVIG on BKPyV infection, allograft function, allograft loss, acute tran…

Australia280 participantsStarted 2023-08-18

Treatment: Immunosuppression reduction/modification + intravenous immunoglobulin, Immunosuppression reduction/modification

All recent trials (22 shown)

Not Yet RecruitingPhase 2

NCT07503561

A Study to Understand How a New, Unlicensed Drug (AIC468) Works, Compared With a Placebo, Against BK Virus in Patients W…

The goal of this clinical trial is to learn if AIC263029 is safe and well tolerated in adult kidney transplant recipients with BK virus (BKV) in the blood (vire…

Location not specified24 participantsStarted 2026-06-15

Treatment: AIC263029, Placebo

WithdrawnNot Applicable

NCT04984902

Reduction of BK Viremia in Kidney Transplant Patients

Reduction of BK Viremia by treating kidney transplant patients.

Germany0Started 2022-02-01

Treatment: Extracorporal therapy

BK Viremia

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

All recent trials (22 shown)

A Study to Understand How a New, Unlicensed Drug (AIC468) Works, Compared With a Placebo, Against BK Virus in Patients W…

Reduction of BK Viremia in Kidney Transplant Patients

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

All recent trials (22 shown)

A Study to Understand How a New, Unlicensed Drug (AIC468) Works, Compared With a Placebo, Against BK Virus in Patients W…

Reduction of BK Viremia in Kidney Transplant Patients

Prevalence of BK Viremia in Simultaneous Liver-Kidney Transplant

Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals…

Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.

Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients

Study of Anti-BKPyV Immune Responses in Kidney Transplant Patients With BKPyV Viremia

Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kid…

Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia

Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia

A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients

IVIg to Treat BK Viremia in Kidney Transplant Recipients

BK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach

BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients

Ciprofloxacin for Prevention of BK Infection

An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria

Using mTOR Inhibitors in the Prevention of BK Nephropathy

Role of Everolimus in Highly Sensitized Patients

BK Treatment Study

Induction Related BK Viremia in Renal Transplant Patients